Mental Health Symptoms Among Street-Based Psychostimulant Injectors in Sydney's Kings Cross

References

• ABS (Australian Bureau of Statistics). (2006). 2004–05 National Health Survey: summary of results. Canberra, Australia: Australian Bureau of Statistics.
   Google Scholar
• Andrews, G., Slade, T. (2001). Interpreting scores on the Kessler Psychological Distress Scale (K10). Australian and New Zealand Journal of Public Health, 25:494–497.
   PubMed Web of Science ®Google Scholar
• Baker, A., Dawe, S. (2005). Amphetamine use and co-occurring psychological problems: review of the literature and implications for treatment. Australian Psychologist, 40:88–95.
   Web of Science ®Google Scholar
• Baker, A., Lee, N., Clarie, M., Lewin, T. J., Grant, T., Pohlman, S., Saunders, J. B., Kay-Lambkin, F., Constable, P., Jenner, L., Carr, V. J. (2004a). Drug use patterns and mental health of regular amphetamine users during a reported “heroin drought.” Addiction, 99:875–884.
   PubMed Web of Science ®Google Scholar
• Baker, A., Lee, N., Jenner, L. (Eds.). (2004b). Models of intervention and care for psychostimulant users. In National drug strategy monograph series no. 51. Canberra, Australia: Australian Government Department of Health and Ageing.
   Google Scholar
• Biernacki, P., Waldorf, D. (1981). Snowball sampling: problems, techniques and chain referral sampling. Sociological Methods and Research, 10:141–163.
   Web of Science ®Google Scholar
• Black, E., Roxburgh, A., Degenhardt, L., Bruno, R., Campbell, G., et al. (2008). Australian drug trends 2007: findings from the illicit drug reporting system. In Australian drug trends series no. 1. Sydney: National Drug and Alcohol Research Centre.
   Google Scholar
• Bourgois, P., Prince, B., Moss, A. (2004). The everyday violence of hepatitis C among young women who inject drugs in San Francisco. Human Organization, 63:253–264.
   PubMed Web of Science ®Google Scholar
• Brady, K. T., Grice, D. E., Dunstan, L., Randall, C. (1993). Gender differences in substance use disorders. American Journal of Psychiatry, 150:1707–1711.
   PubMed Web of Science ®Google Scholar
• Castle, D., Daniel, J., Knott, J., (2005). Development of clinical guidelines for the pharmacological management of behavioural disturbance and aggression in people with psychosis. Australasian Psychiatry, 13:247–252.
   PubMedGoogle Scholar
• Darke, S., Cohen, J., Ross, J., Hando, J., Hall, W. (1994). Transitions between routes of administration of regular amphetamine users. Addiction, 89:1077–1083.
   PubMed Web of Science ®Google Scholar
• Darke, S., Kaye, S. (2004). Attempted suicide among injecting and noninjecting cocaine users in Sydney, Australia. Journal of Urban Health, 81:505–515.
   PubMed Web of Science ®Google Scholar
• Darke, S., Ross, J. (1997). Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug and Alcohol Dependence, 48:135–141.
   PubMed Web of Science ®Google Scholar
• Darke, S., Ross, J. (2002). Suicide among heroin users: rates, risk factors and methods. Addiction, 97:1383–1394.
   PubMed Web of Science ®Google Scholar
• Day, C., Topp, L. (2003). Safety in drug and alcohol research. Addiction, 98:1641–1643.
   PubMedGoogle Scholar
• Degenhardt, L., Day, C., Dietze, P., (2005). Effects of a sustained heroin shortage in three Australian States. Addiction, 100:908–920.
   PubMed Web of Science ®Google Scholar
• De Graaf, B., Bruno, R. (2007). Self-reported mental health problems amongst regular injecting drug users interviewed in the IDRS. Drug Trends Bulletin, April 2007. Sydney: National Drug and Alcohol Research Centre. Retrieved October 3, 2008, from National Drug and Alcohol Research Centre, University of New South Wales Web site file/IDRS±Bulletin±April±2007.pdf">http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/Bulletins_2007/$file/IDRS±Bulletin±April±2007.pdf">file/IDRS±Bulletin±April±2007.pdf.
   Google Scholar
• Estroff, T. W. (1987). Medical and biological consequences of cocaine abuse. In A. M. Washton and M. S. Gold (Eds.), Cocaine: a clinician's handbook, pp. 23–32. New York: Guildford Press.
   Google Scholar
• Farrell, M., Marsden, J., Ali, R., Ling, W. (2002). Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction, 97:771–772.
   PubMed Web of Science ®Google Scholar
• Fry, C., Dwyer, R. (2001). For love or money? An exploratory study of why injecting drug users participate in research. Addiction, 96:1319–1325.
   PubMed Web of Science ®Google Scholar
• Furukawa, T. A., Kessler, R. C., Slade, T., Andrews, G. (2003). The performance of the K6 and K10 screening scales for psychological distress in the Australian national survey of mental health and well-being. Psychological Medicine, 33:357–362.
   PubMed Web of Science ®Google Scholar
• Galea, S., Vlahov, D. (2002). Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Reports, 117(Suppl 1):S135–S145.
   PubMed Web of Science ®Google Scholar
• Graham, H. L. (2004). Implementing integrated treatment for coexisting substance use and severe mental health problems in assertive outreach teams: training issues. Drug and Alcohol Review, 23:463–470.
   PubMed Web of Science ®Google Scholar
• Grann, M., Fazel, S. (2004). Substance misuse and violent crime: Swedish population study. British Medical Journal, 328:1233–1234.
   PubMed Web of Science ®Google Scholar
• Griffin, M. L., Weiss, R. D., Mirin, S. M., Lange, U. (1989). A comparison of male and female cocaine abusers. Archives of General Psychiatry, 46:122–126.
   PubMed Web of Science ®Google Scholar
• Hall, W., Hando, J. (1994). Routes of administration and adverse effects of amphetamine use among young adults in Sydney, Australia. Drug and Alcohol Review, 13:277–284.
   PubMedGoogle Scholar
• Hall, W., Hando, J., Darke, S., Ross, J. (1996). Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction, 91:81–87.
   PubMed Web of Science ®Google Scholar
• Hando, J., Darke, S., O’Brien, S., Maher, L., Hall, W. (1998). The development of an early warning system to detect trends in illicit drug use in Australia: the illicit drug reporting system. Addiction Research, 6:97–113.
   Web of Science ®Google Scholar
• Henderson, S., Andrews, G., Hall, W. (2000). Australia's mental health: an overview of the general population survey. Australian and New Zealand Journal of Psychiatry, 34:197–205.
   PubMed Web of Science ®Google Scholar
• Hides, L., Lubman, D. I., Devlin, H., Cotton, S., Aitken, C., Gibbie, T., (2007). Reliability and validity of the Kessler 10 and patient health questionnaire among injecting drug users. Australian and New Zealand Journal of Psychiatry, 41:166–168.
   PubMed Web of Science ®Google Scholar
• Houlahan, J., Nicholls, G., Chow, F., Hudson, B. (2007). St Vincent's Hospital guidelines for the treatment of methamphetamine intoxication. Sydney: St Vincent's Hospital.
   Google Scholar
• Hser, Y.-I., Huang, D., Teruya, C., Anglin, M. D. (2003). Gender comparisons of drug abuse treatment outcomes and predictors. Drug and Alcohol Dependence, 72:255–264.
   PubMed Web of Science ®Google Scholar
• Hudson, S. L. (2006). Exploring the experiences of street-based sex workers who inject psychostimulants. Paper presented at the Australasian Professional Society on Alcohol and Other Drugs (APSAD) Annual Conference “Drugs: Meeting New Challenges,” November 5–8, Cairns, Queensland, Australia.
   Google Scholar
• Hudson, S. L., Maher, L. (2006). A decent proposal: using ethnography to explore the experiences of street sex workers who inject psychostimulants. Poster presented at the XVII International Conference on the Reduction of Drug-Related Harm, April 30–May 4, Vancouver, Canada.
   Google Scholar
• Iversen, J., Topp, L., Maher, L. (2007). Australian NSP survey national data report 2002–2006. Sydney: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales.
   Google Scholar
• Jenkins, R., Lewis, G., Bebbington, P., Brugha, T., Farrell, M., Gill, B., (1997). The national psychiatric morbidity surveys of Great Britain—initial findings from the household survey. Psychological Medicine, 27:775–789.
   PubMed Web of Science ®Google Scholar
• Jenkinson, R., Dietze, P., Jolley, D. (2007). Young risk-takers: bingeing, overdose, injecting and other risk practices among a sample of young psychostimulant users. Paper presented at the 18th International Conference on the Reduction of Drug Related Harm, May 13–17, Warsaw, Poland.
   Google Scholar
• Jenner, L., Baker, A., Whyte, I., Carr, V. (2004a). Management of patients with psychostimulant use problems—guidelines for general practitioners. Canberra, Australia: Australian Government Department of Health and Ageing.
   Google Scholar
• Jenner, L., Baker, A., Whyte, I., Carr, V. (2004b). Psychostimulants: management of acute behavioural disturbances. Guidelines for police services. Canberra, Australia: Australian Government Department of Health and Ageing.
   Google Scholar
• Jenner, L., Spain, D., Whyte, I., Baker, A., Carr, V., Crilly, J. (2006). Management of patients with psychostimulant toxicity: guidelines for emergency departments. Canberra, Australia: Australian Government Department of Health and Ageing.
   Google Scholar
• Karpati, A., Galea, S., Awerbuch, T., Levins, R. (2002). Variability and vulnerability at the ecological level: implications for understanding the social determinants of health. American Journal of Public Health, 92:1768–1772.
   PubMedGoogle Scholar
• Kaye, S., Darke, S. (2000). A comparison of the harms associated with the injection of heroin and amphetamines. Drug and Alcohol Dependence, 58:189–195.
   PubMed Web of Science ®Google Scholar
• Kaye, S., Darke, S. (2004). Injecting and noninjecting cocaine use in Sydney, Australia: physical and psychological morbidity. Drug and Alcohol Review, 23:391–398.
   PubMed Web of Science ®Google Scholar
• Kay-Lambkin, F. J., Baker, A. L., Lewin, T. J. (2004). The “comorbidity roundabout”: a framework to guide assessment and intervention strategies and engineer change among people with comorbid problems. Drug and Alcohol Review, 23:407–423.
   PubMed Web of Science ®Google Scholar
• Kerr, T., Kimber, J., Rhodes, T. (2007). Drug use settings: an emerging focus for research and intervention. International Journal of Drug Policy, 18:1–4.
   PubMed Web of Science ®Google Scholar
• Kessler, R. C., Andrews, G., Colpe, L. J., (2002). Short screening scales to monitor population prevalences and trends in nonspecific psychological distress. Psychological Medicine, 32:959–976.
   PubMed Web of Science ®Google Scholar
• Kidorf, M., Disney, E., King, V. L., Neufeld, K., Beilenson, M. D., Brooner, R. K. (2004). Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug and Alcohol Dependence, 74:115–122.
   PubMed Web of Science ®Google Scholar
• Kirketon Road Centre. (2004). The clinical protocol for the management of delirium. In NSW Department of Health (Ed.), The 2003 Baxter health awards: winners and finalists. Sydney: NSW Department of Health. Retrieved August 6, 2008, from http://mhcs.health.nsw.gov.au/pubs/2004/pdf/baxter_winners.pdf
   Google Scholar
• MacRae, R., Aalto, E. (2000). Gendered power dynamics and HIV risk in drug-using sexual relationships. AIDS Care, 12:505–515.
   PubMed Web of Science ®Google Scholar
• Maher, L., Dixon, D., Lynskey, M., Hall, W. (1998). Running the risks: heroin, health and harm in South West Sydney. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
   Google Scholar
• Maher, L., Li, J., Jalaludin, B., Chant, K. G., Kaldor, J. M. (2007). High hepatitis C incidence in new injecting drug users: a policy failure? Australian and New Zealand Journal of Public Health, 31:30–35.
   PubMed Web of Science ®Google Scholar
• March, J. C., Oviedo-Joekes, E., Romero, M. (2006). Drugs and social exclusion in ten European cities. European Addiction Research, 12:33–41.
   PubMed Web of Science ®Google Scholar
• McCann, U. D., Ricaurte, G. A. (2000). Drug abuse and dependence: hazards and consequences of heroin, cocaine and amphetamines. Current Opinion in Psychiatry, 13:321–325.
   Web of Science ®Google Scholar
• McKeganey, N. (2001). To pay or not to pay: respondents’ motivations for participating in research (Editorial). Addiction, 96:1237–1238.
   PubMed Web of Science ®Google Scholar
• McKetin, R., McLaren, J., Lubman, D. I., Hides, L. (2006a). The prevalence of psychotic symptoms among methamphetamine users. Addiction, 101:1473–1478.
   PubMed Web of Science ®Google Scholar
• McKetin, R., McLaren, J., Riddell, S., Robins, L. (2006b). The relationship between methamphetamine use and violent behaviour. Crime and Justice Bulletin, 97. Sydney: NSW Bureau of Crime Statistics and Research, Attorney-General's Department.
   Google Scholar
• Moore, D., Dietze, P. (2005). Enabling environments and the reduction of drug-related harm: re-framing Australian policy and practice. Drug and Alcohol Review, 24:275–284.
   PubMed Web of Science ®Google Scholar
• Moore, D., Dietze, P., Maher, L., Bammer, G., Clatts, M. C. (2004). Improving understanding of psychostimulant-related harms in Australia: an integrated ethno-epidemiological approach. Centrelines, 14:4.
   Google Scholar
• National Centre in HIV Epidemiology and Clinical Research. (2007). Sydney medically supervised injecting centre interim evaluation report 3: evaluation of client referral and health issues. Sydney: NCHECR, University of New South Wales.
   Google Scholar
• National Health and Medical Research Council, Australian Research Council and Australian Vice-Chancellor's Committee. (2007). National statement on ethical conduct in human research. Canberra, Australia: Australian Government.
   Google Scholar
• Neale, J. (2001). Homelessness among drug users: a double jeopardy explored. International Journal of Drug Policy, 12:353–369.
   Google Scholar
• Offord, D.R., Boyle, M.H., Campbell, D., Goering, P., Lin, E., Wong, M. & Racine, Y.A. (1996) One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Canadian Journal of Psychiatry, 41:559–563.
   PubMed Web of Science ®Google Scholar
• Rhodes, T. (2002). The “risk environment”: a framework for understanding and reducing drug-related harm. International Journal of Drug Policy, 13:85–94.
   Google Scholar
• Rhodes, T., Stimson, G., Crofts, N., Ball, A., Dehne, K., Khodakevich, L. (1999). Drug injecting, rapid HIV spread, and the “risk environment”: implications for assessment and response. AIDS, 13(Suppl A):S259–S269.
   PubMed Web of Science ®Google Scholar
• Rhodes, T., Watts, L., Davies, S., (2007). Risk, shame and the public injector: a qualitative study of drug injecting in South Wales. Social Science and Medicine, 65:572–585.
   PubMed Web of Science ®Google Scholar
• Ross, J., Teesson, M., Darke, S., (2005). The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS). Drug and Alcohol Review, 24:411–418.
   PubMed Web of Science ®Google Scholar
• Rowe, J. (2004). Needles and syringes to care and counselling: the need for innovative primary health care to meet the needs of street-based injecting drug users. Australian Journal of Primary Health, 10:49–55.
   Google Scholar
• Singer, M. (1994). AIDS and the health crisis of the urban poor: the perspective of critical medical anthropology. Social Science and Medicine, 39:931–948.
   PubMed Web of Science ®Google Scholar
• Small, W., Rhodes, T., Wood, E., Kerr, T. (2007). Public injection settings in Vancouver: physical environment, social context, and risk. International Journal of Drug Policy, 18:27–36.
   PubMed Web of Science ®Google Scholar
• Southgate, E., Day, C., Dolan, K., Kimber, J., McGuckin, S., Woolcock, G., MacDonald, M., Weatherall, A. M. (2003). Conclusions: Dealing with risk — a synthesis of findings from this report. In: E. Southgate, C. Day, J. Kimber, A.M. Weatherall, M. MacDonald, G. Woolcock, S. McGuckin, & K. Dolan (Eds.), Dealing with Risk: A multidisciplinary study of injecting drug use, hepatitis c and other blood-borne viruses in Australia. ANCD Research Paper Series No. 7. Canberra, Australia: Australian National Council on Drugs.
   Google Scholar
• Spittal, P. M., Craib, K. J. P., Wood, E., Laliberté, N., Li, K., Tyndall, M. W., (2002). Risk factors for elevated incidence rates among female injection drug users in Vancouver. Canadian Medical Association Journal, 166:894–899.
   PubMed Web of Science ®Google Scholar
• Spittal, P. M., Schechter, M. T. (2001). Injection drug use and despair through the lens of gender. Canadian Medical Association Journal, 164:802–803.
   Web of Science ®Google Scholar
• SPSS Inc. (2007). SPSS for Windows, Release 15.0. Chicago, IL: SPSS Inc.
   Google Scholar
• St Vincent's Hospital. (2006–2007). Emergency department presentation data. Sydney: St Vincent's Hospital.
   Google Scholar
• Teesson, M., Hall, W., Lynksey, M., Degenhardt, L. (2000). Alcohol- and drug-use disorders in Australia: implications of the national survey of mental health and wellbeing. Australian and New Zealand Journal of Psychiatry, 34:206–213.
   PubMed Web of Science ®Google Scholar
• Teesson, M., Harvard, A., Fairbairn, S., Ross, J., Lynskey, M., Darke, S. (2005). Depression among entrants to treatment for heroin dependence in the Australian treatment outcome study (ATOS): prevalence, correlates and treatment seeking. Drug and Alcohol Dependence, 78:309–15.
   PubMed Web of Science ®Google Scholar
• Topp, L., Breen, C., Kaye, S., Darke, S. (2004). Adapting the illicit drug reporting system (IDRS). to examine the feasibility of monitoring trends in the markets for “party drugs.” Drug and Alcohol Dependence, 73:189–197.
   PubMed Web of Science ®Google Scholar
• Topp, L., Day, C., Degenhardt, L. (2003). Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug and Alcohol Dependence, 70:275–286.
   PubMed Web of Science ®Google Scholar
• Topp, L., Hando, J., Dillon, P., Roche, A., Solowij, N. (1999). Ecstasy use in Australia: patterns of use and associated harms. Drug and Alcohol Dependence, 55:105–115.
   PubMed Web of Science ®Google Scholar
• Urbanowski, K. A., Cairney, J., Bassani, D. G., Rush, B. R. (2008). Perceived unmet need for mental health care for Canadians with co-occurring mental and substance use disorders. Psychiatric Services, 59:283–289.
   PubMedGoogle Scholar
• van Beek, I. (2007). Case study: accessible primary health care—a foundation to improve health outcomes for people who inject drugs. International Journal of Drug Policy, 18:329–332.
   PubMed Web of Science ®Google Scholar
• van Beek, I., Dwyer, R., Malcolm, R. (2001). Cocaine injecting: the sharp end of drug-related harm! Drug and Alcohol Review, 20:333–342.
   Google Scholar
• Wallen, J. (1992). A comparison of male and female clients in substance abuse treatment. Journal of Substance Abuse Treatment, 9:243–248.
   PubMed Web of Science ®Google Scholar
• Watkins, K. E., Burnam, A., Kung, F.-Y., Paddock, S. (2001). A survey of care for persons with co-occurring mental and substance use disorders. Psychiatric Services, 52:1062–1069.
   PubMed Web of Science ®Google Scholar
• Wittchen, H.-U., Jacobi, F. (2005). Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies. European Neuropharmacology, 15:357–376.
   PubMed Web of Science ®Google Scholar
• Zilberman, M. L., Tavares, H., Blume, S. B., el-Guebaly, N. (2003). Substance use disorders: sex differences and psychiatric comorbidities. Canadian Journal of Psychiatry, 48:5–13.
   PubMed Web of Science ®Google Scholar
• Zweben, J. E., Cohen, J. B., Christian, D., (2004). Psychiatric symptoms in methamphetamine users. American Journal of Addiction, 13:181–190.
   PubMed Web of Science ®Google Scholar